ZYXI News and Press, Zynex Inc. From 01/12/21

Zynex ([[ZYXI]] +3.7%) reaffirms its previous revenue estimate for 4Q20 to be in rage of $25.5M and $26.5M vs. $25.60M consensus; and FY20 revenue estimate between $80M and $81M vs. $ 80.12M consensus.Zynex increases its adj. EBITDA estimate to between $3.1M and $4.1M (prior $2.3M and $3.3M);...

Zynex Announces 117% Year over Year Order Growth and Increases Adjusted EBITDA Estimate PR Newswire ENGLEWOOD, Colo. , Jan. 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and sellin...

Zynex exits Q3 with another sequential growth period in revenues and market share, with significant YoY comparisons. Valuations balance out to be attractive, and we feel shares are worth ~$27, based on gross profit multiples as a cleaner measure. Significant headwinds to operating...

Medical device maker Zynex ([[ZYXI]] +5.2%) announces that it has obtained a second U.S. Utility patent for its blood volume monitor device.Zynex's first generation CM-1500 device is cleared by the FDA and is already in full production.Thomas Sandgaard, CEO of Zynex, has a...

Zynex Announces a Second Utility Patent for Its Blood Volume Monitor PR Newswire ENGLEWOOD, Colo. , Jan. 6, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive med...

It's easier to find bargains in the stock market if you look at high-quality small-cap stocks because not many investors have an appetite for these lesser known names. For perspective, the Russell 2000 , an index tracking small-cap stocks, rose 18.4% in 2020, outperforming the S&...

Click here to read the previous top NASDAQ medical device stocks article. The growing prevalence of chronic diseases such as cancer and diabetes is driving increasing innovation in medical device technology . As of mid-December 2020, 49 new devices had been approve...

Zynex Ranked 13th in Revenue Growth Among Medical Device Companies PR Newswire ENGLEWOOD, Colo., Nov. 19, 2020 ENGLEWOOD, Colo., Nov. 19, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufa...

Zynex to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference PR Newswire ENGLEWOOD, Colo., Nov. 17, 2020 ENGLEWOOD, Colo., Nov. 17, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializ...

Zynex, Inc. (ZYXI) Q3 2020 Earnings Conference Call October 27, 2020 4:15 PM ET Company Participants Thomas Sandgaard - Founder, Chairman, and Chief Executive Officer Dan Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Yi Chen - HC Wainwright...